Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$14.85 - $19.04 $109,949 - $140,972
-7,404 Reduced 2.98%
240,762 $3.95 Million
Q3 2022

Nov 14, 2022

SELL
$12.38 - $20.23 $8.53 Million - $13.9 Million
-689,151 Reduced 73.52%
248,166 $4.59 Million
Q2 2022

Aug 15, 2022

SELL
$9.11 - $13.98 $9.31 Million - $14.3 Million
-1,021,761 Reduced 52.16%
937,317 $12.3 Million
Q1 2022

May 13, 2022

BUY
$6.87 - $11.11 $7.49 Million - $12.1 Million
1,090,368 Added 125.52%
1,959,078 $18.2 Million
Q4 2021

Feb 14, 2022

BUY
$7.7 - $37.13 $6.69 Million - $32.3 Million
868,710 New
868,710 $8.49 Million
Q1 2021

May 13, 2021

SELL
$40.39 - $56.73 $289,879 - $407,151
-7,177 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$51.77 - $66.18 $369,482 - $472,326
7,137 Added 17842.5%
7,177 $410,000
Q3 2020

Nov 12, 2020

SELL
$43.8 - $58.16 $101,397 - $134,640
-2,315 Reduced 98.3%
40 $2,000
Q2 2020

Aug 13, 2020

SELL
$37.05 - $65.03 $7.27 Million - $12.8 Million
-196,148 Reduced 98.81%
2,355 $141,000
Q1 2020

May 13, 2020

SELL
$33.63 - $69.4 $1.34 Million - $2.76 Million
-39,774 Reduced 16.69%
198,503 $8.17 Million
Q4 2019

Feb 14, 2020

BUY
$31.7 - $69.93 $7.29 Million - $16.1 Million
230,033 Added 2790.31%
238,277 $14.8 Million
Q3 2019

Nov 14, 2019

SELL
$19.95 - $38.85 $409,214 - $796,891
-20,512 Reduced 71.33%
8,244 $280,000
Q3 2018

Nov 13, 2018

BUY
$33.57 - $42.1 $965,338 - $1.21 Million
28,756 New
28,756 $1.11 Million

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.